Table 2.
Patient characteristics. Patients were admitted to the rehabilitation measures between August, 2014, and end of September, 2018. Shown are mean values and standard deviation (SD) of sociodemographic and clinical data. Assignment of cancer entities was performed according to the respective ICD-10 codes (German Modification) of the primary diagnoses
| Sample size | 4401 | |
| Mean age (SD) | 61.3 yr | (SD 12.0) |
| Range | 31–90 yr | |
| Sex | ||
| Male | 1653 | 37.6% |
| Female | 2746 | 62.4% |
| Missing information | 2 | 0.05% |
| Mean body mass index/BMI (SD) | 25.7 kg/m2 | (5.1) |
| Range | 14.4–53.4 kg/m2 | |
| Smokers | 751 | 17.1 % |
| Karnofsky Performance Score | ||
| High level of functioning (80–100%) | 1,556 | 35.4% |
| Medium level of functioning (50–80%) | 2,763 | 62.8% |
| Low level of functioning (0–50%) | 26 | 0.6% |
| Missing information | 56 | 1.3% |
| ECOG score | ||
| Grade 0 | 368 | 8.4% |
| Grade 1 | 2,447 | 55.6% |
| Grade 2 | 1,457 | 33.1% |
| Grade 3 | 58 | 1.3% |
| Missing information | 71 | 1.6% |
| Cancer entities | ||
| Head and neck cancers (C00-14; C30-C32) | 232 | 5.3% |
| Esophageal cancer (C15) | 64 | 1.5% |
| Gastric cancer (C16) | 120 | 2.7% |
| Colon cancer (C18-19) | 261 | 5.9% |
| Rectal cancer (C20-21) | 151 | 3.4% |
| Liver cancer (C22) | 35 | 0.8% |
| Pancreatic cancer (C25) | 99 | 2.2% |
| Lung cancers (C33-C34) | 219 | 5.0% |
| Skin cancers (C43-44) | 41 | 0.9% |
| Breast cancer (C50) | 1,534 | 34.9% |
| Uterine cancers (C51-55) | 140 | 3.2% |
| Ovarian cancer (C56) | 152 | 3.5% |
| Prostate cancer (C61) | 323 | 7.3% |
| Testicular cancer (C62) | 43 | 1.0% |
| Renal cancer (C64) | 86 | 2.0% |
| Bladder cancer (C67) | 99 | 2.2% |
| Brain cancers (C70-72) | 59 | 1.3% |
| Thyroid cancer (C73) | 45 | 1.0% |
| Malignant lymphomas (C81-C86; C88) | 299 | 6.8% |
| Multiple myeloma (C90) | 72 | 1.6% |
| Leukemias (C91-C95) | 79 | 1.8% |
| Other cancer types | 248 | 5.6% |